Sheldon Litwin to Disease-Free Survival
This is a "connection" page, showing publications Sheldon Litwin has written about Disease-Free Survival.
Connection Strength
0.046
-
Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib. Cancer Chemother Pharmacol. 2012 Apr; 69(4):977-82.
Score: 0.023
-
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. J Clin Oncol. 1995 Aug; 13(8):1860-70.
Score: 0.008
-
Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience. Semin Oncol. 1995 Aug; 22(4 Suppl 9):18-29.
Score: 0.008
-
A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. Am J Surg. 1995 Jan; 169(1):71-7; discussion 77-8.
Score: 0.007